The Valley Desk

ReviewCNS drugsPublished

The Role of Long-Acting Injectable Antipsychotics in the Early Treatment of Schizophrenia

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Review
Venue
CNS drugs
Published
Subject terms
Humans; Antipsychotic Agents; Delayed-Action Preparations; Treatment Outcome; Injections; Schizophrenia; Medication Adherence
PubMed ID
42201608
PubMed Central ID
PMC13303331
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal